Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: NEUROBLASTOMA - GENETICS , . Treffer: 11

2017

Abbasi, MR; Rifatbegovic, F; Brunner, C; Mann, G; Ziegler, A; Pötschger, U; Crazzolara, R; Ussowicz, M; Benesch, M; Ebetsberger-Dachs, G; Chan, GCF; Jones, N; Ladenstein, R; Ambros, IM; Ambros, PF Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.
Clin Cancer Res. 2017; 23(15):4224-4232 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gürtl-Lackner, B; Gisselsson-Nord, D; Vujanic, G [Solid pediatric tumors : A brief survey of the rarity cabinet].
Pathologe. 2017; 38(4):278-285 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Bogen, D; Brunner, C; Walder, D; Ziegler, A; Abbasi, R; Ladenstein, RL; Noguera, R; Martinsson, T; Amann, G; Schilling, FH; Ussowicz, M; Benesch, M; Ambros, PF; Ambros, IM The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.
Int J Cancer. 2016; 139(1):153-163 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Löffler, T; Flunkert, S; Taub, N; Schofield, EL; Ward, MA; Windisch, M; Hutter-Paier, B Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates.
J Mol Neurosci. 2012; 47(1): 192-203. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Fiegel, HC; Kaifi, JT; Quaas, A; Varol, E; Krickhahn, A; Metzger, R; Sauter, G; Till, H; Izbicki, JR; Erttmann, R; Kluth, D Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival
Pediatr Surg Int. 2008; 24(1):101-105
Web of Science PubMed FullText FullText_MUG

 

2003

Kerbl, R; Urban, CE; Ambros, IM; Dornbusch, HJ; Schwinger, W; Lackner, H; Ladenstein, R; Strenger, V; Gadner, H; Ambros, PF Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
J Clin Oncol. 2003; 21(22):4228-4234 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Behrends, U; Jandl, T; Golbeck, A; Lechner, B; Muller-Weihrich, S; Schmid, I; Till, H; Berthold, F; Voltz, R; Mautner, JM Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library
Int J Cancer. 2002; 100(6):669-677
Web of Science PubMed FullText FullText_MUG

 

2001

Ambros, PF; Ambros, IM; Kerbl, R; Luegmayr, A; Rumpler, S; Ladenstein, R; Amann, G; Kovar, H; Horcher, E; De Bernardi, B; Michon, J; Gadner, H Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
Med Pediatr Oncol. 2001; 36(1):1-4
Web of Science PubMed FullText FullText_MUG

 

1998

Erttmann, R; Tafese, T; Berthold, F; Kerbl, R; Mann, J; Parker, L; Schilling, F; Ambros, P; Christiansen, H; Favrot, M; Kabisch, H; Hero, B; Philip, T 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).
Eur J Cancer. 1998; 34(9):1391-1397
Web of Science PubMed FullText FullText_MUG

 

1995

Ambros, PF; Ambros, IM; Strehl, S; Bauer, S; Luegmayr, A; Kovar, H; Ladenstein, R; Fink, FM; Horcher, E; Printz, G Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
Eur J Cancer. 1995; 31A(4):510-515
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1993

Kerbl, R; Urban, C; Starz, I; Ambros, IM; Strehl, S; Kovar, H; Gadner, H; Ambros, PF Neuroblastoma with N-myc amplification detected by urine: mass screening in infants after the sixth month of life.
Med Pediatr Oncol. 1993; 21(9):625-626
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum